Neha Debnath
LightNews LightNews
banner
nehadebnath.bsky.social
Neha Debnath
@nehadebnath.bsky.social
92 followers 360 following 2 posts
Nephrology fellow @StanfordNeph | Residency@MountSinaiNYC| Med-Ed @HarvardMacy #WomenInMedicine

https://scholar.google.com/citations?user=383_GA8AAAAJ&hl=en
Posts Replies Media Videos
Reposted by Neha Debnath
theisn.org
Kidney health is gaining global attention. 🌐

As #UNGA tackles UHC & NCDs, the ISN-GKHA Interactive Map reveals/highlights:

📊 Access to dialysis & transplant
👩‍⚕️ Workforce gaps
💰 Health financing across countries
Explore insights 👉 http://lite.spr.ly/6...
#HLM4 #KidneyHealthMatters
September 22, 2025 at 1:00 PM
Reposted by Neha Debnath
dukekidney.bsky.social
New ASN Kidney Translation Podcast hosted by Dr Sparks is out

discussing the new ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives with co-chairs Dr Biruete and Dr Kovesky

📰 here
journals.lww.com/jas...

🎧 here
September 22, 2025 at 6:20 PM
Reposted by Neha Debnath
nkf-professionals.bsky.social
🩺 Considering transplant as a treatment?

This course walks you through every step of the kidney transplant journey — from evaluation to post-transplant care.

✨ CE Credit Available

📚 Start learning: bit.ly/42yd3i9
September 22, 2025 at 4:02 PM
Reposted by Neha Debnath
hswapnil.medsky.social
As therapies in GN explode, the nephrology blogfather @kdjhaveri.bsky.social reviews the classes of drugs

www.nephronpower.com/2025/09/in-n...

#NephSky
In the News: B cell and plasma cell therapies in Glomerular Diseases
G lomerular diseases often result from loss of immune tolerance, leading to the production of autoantibodies by plasmablasts/plasma cells. B...
www.nephronpower.com
September 22, 2025 at 1:59 AM
Reposted by Neha Debnath
asnpublications.bsky.social
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894

@ashunephro.bsky.social @sophieclaudel.bsky.social
September 17, 2025 at 4:00 PM
nehadebnath.bsky.social
That’s a wrap for the 2025 ASN HDU course in Chicago! Invaluable learning experience for fellows and big steps ahead for PD, HHD, and access to Home Dialysis. #ASN #HDU #ASNEPC #PeritonealDialysis #Homedialysis
@pd-perls.bsky.social
September 16, 2025 at 6:20 PM
Reposted by Neha Debnath
nkf-professionals.bsky.social
🚦 New CE course alert!

Get a comprehensive overview of the kidney transplant journey—from evaluation to living donor vs. waitlist transplants.

🧠 Build your knowledge

📋 Support your patients

🎧 Start learning: bit.ly/42yd3i9
September 16, 2025 at 4:02 PM
Reposted by Neha Debnath
nephjc.bsky.social
❤️Check out the VA for the discussion on the AHA/ACC Hypertension Guidelines 9/16/25 at 9pm EST by @sejalplakhani.bsky.social #NephJC #NephSky #MedSky
www.nephjc.com/news/2025/9/ahaacc-htnguide
The AHA/ACC 2025 Hypertension Guidelines visual abstract — NephJC
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment. Check out this wonderfu...
www.nephjc.com
September 16, 2025 at 11:47 AM
Reposted by Neha Debnath
nephrosparks.bsky.social
Take a listen to all of the @asnpublications.bsky.social ASN Kidney Translation Kidney Podcast series here

journals.lww.com/asnjournals/...
September 15, 2025 at 9:25 PM
Reposted by Neha Debnath
grahamabra.bsky.social
Have hyperglycemia (and other DM badness) been hiding in plain sight in ESKD?

Probably.

Great study using CGMs in ESKD.

Pts with treated DM, mean TIR only 43% while mean HbA1c was 7.0%

journals.lww.com/jasn/abstrac...
Glycemia Assessed by Continuous Glucose Monitoring among... : Journal of the American Society of Nephrology
ilure and its treatments disrupt glucose homeostasis in ways that may promote both hyperglycemia and hypoglycemia. Continuous glucose monitoring (CGM) delineates detailed glycemic profiles, but publis...
journals.lww.com
September 13, 2025 at 7:16 PM